nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—Methotrexate—lymphatic system cancer	0.661	1	CbGbCtD
Benazepril—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00213	0.0063	CcSEcCtD
Benazepril—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00213	0.00629	CcSEcCtD
Benazepril—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00211	0.00625	CcSEcCtD
Benazepril—Flushing—Teniposide—lymphatic system cancer	0.00208	0.00614	CcSEcCtD
Benazepril—Sinusitis—Fludarabine—lymphatic system cancer	0.00206	0.00608	CcSEcCtD
Benazepril—Arrhythmia—Teniposide—lymphatic system cancer	0.002	0.00591	CcSEcCtD
Benazepril—Alopecia—Teniposide—lymphatic system cancer	0.00198	0.00585	CcSEcCtD
Benazepril—Pharyngitis—Fludarabine—lymphatic system cancer	0.00195	0.00577	CcSEcCtD
Benazepril—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00186	0.0055	CcSEcCtD
Benazepril—Hyponatraemia—Carmustine—lymphatic system cancer	0.00183	0.0054	CcSEcCtD
Benazepril—Arrhythmia—Fludarabine—lymphatic system cancer	0.00176	0.0052	CcSEcCtD
Benazepril—Face oedema—Carmustine—lymphatic system cancer	0.00176	0.0052	CcSEcCtD
Benazepril—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00175	0.00517	CcSEcCtD
Benazepril—Hyponatraemia—Vincristine—lymphatic system cancer	0.00175	0.00516	CcSEcCtD
Benazepril—Leukopenia—Teniposide—lymphatic system cancer	0.00175	0.00516	CcSEcCtD
Benazepril—Alopecia—Fludarabine—lymphatic system cancer	0.00174	0.00514	CcSEcCtD
Benazepril—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.0017	0.00502	CcSEcCtD
Benazepril—Chest pain—Teniposide—lymphatic system cancer	0.00166	0.00491	CcSEcCtD
Benazepril—Oedema—Teniposide—lymphatic system cancer	0.00159	0.0047	CcSEcCtD
Benazepril—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00159	0.0047	CcSEcCtD
Benazepril—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00159	0.00469	CcSEcCtD
Benazepril—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00159	0.00468	CcSEcCtD
Benazepril—Infection—Teniposide—lymphatic system cancer	0.00158	0.00467	CcSEcCtD
Benazepril—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00158	0.00466	CcSEcCtD
Benazepril—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00156	0.00461	CcSEcCtD
Benazepril—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00154	0.00455	CcSEcCtD
Benazepril—Leukopenia—Fludarabine—lymphatic system cancer	0.00153	0.00453	CcSEcCtD
Benazepril—Pruritus—Mechlorethamine—lymphatic system cancer	0.00153	0.00451	CcSEcCtD
Benazepril—Cough—Fludarabine—lymphatic system cancer	0.0015	0.00442	CcSEcCtD
Benazepril—Hypotension—Teniposide—lymphatic system cancer	0.00149	0.0044	CcSEcCtD
Benazepril—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00148	0.00437	CcSEcCtD
Benazepril—Neutropenia—Carmustine—lymphatic system cancer	0.00147	0.00435	CcSEcCtD
Benazepril—Arthralgia—Fludarabine—lymphatic system cancer	0.00146	0.00431	CcSEcCtD
Benazepril—Myalgia—Fludarabine—lymphatic system cancer	0.00146	0.00431	CcSEcCtD
Benazepril—Dyspnoea—Teniposide—lymphatic system cancer	0.00142	0.00419	CcSEcCtD
Benazepril—Neutropenia—Vincristine—lymphatic system cancer	0.00141	0.00415	CcSEcCtD
Benazepril—Oedema—Fludarabine—lymphatic system cancer	0.0014	0.00413	CcSEcCtD
Benazepril—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0014	0.00413	CcSEcCtD
Benazepril—Infection—Fludarabine—lymphatic system cancer	0.00139	0.00411	CcSEcCtD
Benazepril—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00138	0.00409	CcSEcCtD
Benazepril—Vomiting—Mechlorethamine—lymphatic system cancer	0.00137	0.00406	CcSEcCtD
Benazepril—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00137	0.00405	CcSEcCtD
Benazepril—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00137	0.00405	CcSEcCtD
Benazepril—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00137	0.00404	CcSEcCtD
Benazepril—Urinary tract infection—Carmustine—lymphatic system cancer	0.00136	0.00403	CcSEcCtD
Benazepril—Rash—Mechlorethamine—lymphatic system cancer	0.00136	0.00402	CcSEcCtD
Benazepril—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00136	0.00402	CcSEcCtD
Benazepril—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00135	0.004	CcSEcCtD
Benazepril—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00135	0.00398	CcSEcCtD
Benazepril—Flushing—Bleomycin—lymphatic system cancer	0.00134	0.00396	CcSEcCtD
Benazepril—Proteinuria—Methotrexate—lymphatic system cancer	0.00132	0.00391	CcSEcCtD
Benazepril—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00132	0.0039	CcSEcCtD
Benazepril—Myocardial infarction—Vincristine—lymphatic system cancer	0.00131	0.00388	CcSEcCtD
Benazepril—Protein urine present—Methotrexate—lymphatic system cancer	0.0013	0.00386	CcSEcCtD
Benazepril—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0013	0.00385	CcSEcCtD
Benazepril—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00129	0.0038	CcSEcCtD
Benazepril—Sweating—Vincristine—lymphatic system cancer	0.00128	0.0038	CcSEcCtD
Benazepril—Nausea—Mechlorethamine—lymphatic system cancer	0.00128	0.00379	CcSEcCtD
Benazepril—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00128	0.00378	CcSEcCtD
Benazepril—Alopecia—Bleomycin—lymphatic system cancer	0.00128	0.00377	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00127	0.00377	CcSEcCtD
Benazepril—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00127	0.00375	CcSEcCtD
Benazepril—Abdominal pain—Teniposide—lymphatic system cancer	0.00126	0.00372	CcSEcCtD
Benazepril—Paraesthesia—Fludarabine—lymphatic system cancer	0.00126	0.00371	CcSEcCtD
Benazepril—Sweating—Mitoxantrone—lymphatic system cancer	0.00125	0.0037	CcSEcCtD
Benazepril—Dyspnoea—Fludarabine—lymphatic system cancer	0.00125	0.00369	CcSEcCtD
Benazepril—Oedema peripheral—Carmustine—lymphatic system cancer	0.00124	0.00367	CcSEcCtD
Benazepril—Dyspepsia—Fludarabine—lymphatic system cancer	0.00123	0.00364	CcSEcCtD
Benazepril—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00122	0.00362	CcSEcCtD
Benazepril—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00122	0.0036	CcSEcCtD
Benazepril—Fatigue—Fludarabine—lymphatic system cancer	0.00121	0.00356	CcSEcCtD
Benazepril—Constipation—Fludarabine—lymphatic system cancer	0.0012	0.00354	CcSEcCtD
Benazepril—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00117	0.00347	CcSEcCtD
Benazepril—Hypersensitivity—Teniposide—lymphatic system cancer	0.00117	0.00347	CcSEcCtD
Benazepril—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00117	0.00346	CcSEcCtD
Benazepril—Flushing—Carmustine—lymphatic system cancer	0.00117	0.00346	CcSEcCtD
Benazepril—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00116	0.00344	CcSEcCtD
Benazepril—Asthenia—Teniposide—lymphatic system cancer	0.00114	0.00337	CcSEcCtD
Benazepril—Melaena—Methotrexate—lymphatic system cancer	0.00114	0.00336	CcSEcCtD
Benazepril—Pruritus—Teniposide—lymphatic system cancer	0.00113	0.00333	CcSEcCtD
Benazepril—Arrhythmia—Carmustine—lymphatic system cancer	0.00113	0.00333	CcSEcCtD
Benazepril—Leukopenia—Bleomycin—lymphatic system cancer	0.00113	0.00332	CcSEcCtD
Benazepril—Alopecia—Carmustine—lymphatic system cancer	0.00111	0.00329	CcSEcCtD
Benazepril—Cough—Bleomycin—lymphatic system cancer	0.0011	0.00324	CcSEcCtD
Benazepril—Diarrhoea—Teniposide—lymphatic system cancer	0.00109	0.00322	CcSEcCtD
Benazepril—Chest pain—Bleomycin—lymphatic system cancer	0.00107	0.00316	CcSEcCtD
Benazepril—Myalgia—Bleomycin—lymphatic system cancer	0.00107	0.00316	CcSEcCtD
Benazepril—Alopecia—Vincristine—lymphatic system cancer	0.00106	0.00314	CcSEcCtD
Benazepril—Back pain—Carmustine—lymphatic system cancer	0.00106	0.00314	CcSEcCtD
Benazepril—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00105	0.00309	CcSEcCtD
Benazepril—Alopecia—Mitoxantrone—lymphatic system cancer	0.00104	0.00306	CcSEcCtD
Benazepril—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00103	0.00305	CcSEcCtD
Benazepril—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00103	0.00303	CcSEcCtD
Benazepril—Oedema—Bleomycin—lymphatic system cancer	0.00103	0.00303	CcSEcCtD
Benazepril—Infection—Bleomycin—lymphatic system cancer	0.00102	0.00301	CcSEcCtD
Benazepril—Back pain—Vincristine—lymphatic system cancer	0.00101	0.00299	CcSEcCtD
Benazepril—Vomiting—Teniposide—lymphatic system cancer	0.00101	0.00299	CcSEcCtD
Benazepril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.001	0.00297	CcSEcCtD
Benazepril—Asthenia—Fludarabine—lymphatic system cancer	0.001	0.00297	CcSEcCtD
Benazepril—Rash—Teniposide—lymphatic system cancer	0.001	0.00297	CcSEcCtD
Benazepril—Dermatitis—Teniposide—lymphatic system cancer	0.001	0.00296	CcSEcCtD
Benazepril—Headache—Teniposide—lymphatic system cancer	0.000997	0.00295	CcSEcCtD
Benazepril—Pruritus—Fludarabine—lymphatic system cancer	0.00099	0.00292	CcSEcCtD
Benazepril—Back pain—Mitoxantrone—lymphatic system cancer	0.000987	0.00292	CcSEcCtD
Benazepril—Leukopenia—Carmustine—lymphatic system cancer	0.000982	0.0029	CcSEcCtD
Benazepril—Photosensitivity—Methotrexate—lymphatic system cancer	0.000961	0.00284	CcSEcCtD
Benazepril—Hypotension—Bleomycin—lymphatic system cancer	0.000959	0.00283	CcSEcCtD
Benazepril—Diarrhoea—Fludarabine—lymphatic system cancer	0.000957	0.00283	CcSEcCtD
Benazepril—Nausea—Teniposide—lymphatic system cancer	0.000946	0.00279	CcSEcCtD
Benazepril—Vertigo—Vincristine—lymphatic system cancer	0.000941	0.00278	CcSEcCtD
Benazepril—Leukopenia—Vincristine—lymphatic system cancer	0.000938	0.00277	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000935	0.00276	CcSEcCtD
Benazepril—Chest pain—Carmustine—lymphatic system cancer	0.000934	0.00276	CcSEcCtD
Benazepril—Myalgia—Carmustine—lymphatic system cancer	0.000934	0.00276	CcSEcCtD
Benazepril—Anxiety—Carmustine—lymphatic system cancer	0.000931	0.00275	CcSEcCtD
Benazepril—Paraesthesia—Bleomycin—lymphatic system cancer	0.000921	0.00272	CcSEcCtD
Benazepril—Dyspnoea—Bleomycin—lymphatic system cancer	0.000915	0.0027	CcSEcCtD
Benazepril—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000913	0.0027	CcSEcCtD
Benazepril—Oedema—Carmustine—lymphatic system cancer	0.000896	0.00265	CcSEcCtD
Benazepril—Myalgia—Vincristine—lymphatic system cancer	0.000892	0.00263	CcSEcCtD
Benazepril—Cough—Mitoxantrone—lymphatic system cancer	0.00089	0.00263	CcSEcCtD
Benazepril—Infection—Carmustine—lymphatic system cancer	0.00089	0.00263	CcSEcCtD
Benazepril—Vomiting—Fludarabine—lymphatic system cancer	0.00089	0.00263	CcSEcCtD
Benazepril—Rash—Fludarabine—lymphatic system cancer	0.000882	0.00261	CcSEcCtD
Benazepril—Dermatitis—Fludarabine—lymphatic system cancer	0.000881	0.0026	CcSEcCtD
Benazepril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000877	0.00259	CcSEcCtD
Benazepril—Headache—Fludarabine—lymphatic system cancer	0.000877	0.00259	CcSEcCtD
Benazepril—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000872	0.00258	CcSEcCtD
Benazepril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000868	0.00257	CcSEcCtD
Benazepril—Chest pain—Mitoxantrone—lymphatic system cancer	0.000868	0.00257	CcSEcCtD
Benazepril—Myalgia—Mitoxantrone—lymphatic system cancer	0.000868	0.00257	CcSEcCtD
Benazepril—Anxiety—Mitoxantrone—lymphatic system cancer	0.000865	0.00256	CcSEcCtD
Benazepril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000861	0.00254	CcSEcCtD
Benazepril—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000855	0.00253	CcSEcCtD
Benazepril—Oedema—Vincristine—lymphatic system cancer	0.000855	0.00253	CcSEcCtD
Benazepril—Infection—Vincristine—lymphatic system cancer	0.000849	0.00251	CcSEcCtD
Benazepril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000837	0.00247	CcSEcCtD
Benazepril—Hypotension—Carmustine—lymphatic system cancer	0.000837	0.00247	CcSEcCtD
Benazepril—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000833	0.00246	CcSEcCtD
Benazepril—Oedema—Mitoxantrone—lymphatic system cancer	0.000833	0.00246	CcSEcCtD
Benazepril—Nausea—Fludarabine—lymphatic system cancer	0.000831	0.00246	CcSEcCtD
Benazepril—Infection—Mitoxantrone—lymphatic system cancer	0.000827	0.00244	CcSEcCtD
Benazepril—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000826	0.00244	CcSEcCtD
Benazepril—Shock—Mitoxantrone—lymphatic system cancer	0.000819	0.00242	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000816	0.00241	CcSEcCtD
Benazepril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000815	0.00241	CcSEcCtD
Benazepril—Insomnia—Carmustine—lymphatic system cancer	0.00081	0.00239	CcSEcCtD
Benazepril—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000805	0.00238	CcSEcCtD
Benazepril—Paraesthesia—Carmustine—lymphatic system cancer	0.000804	0.00238	CcSEcCtD
Benazepril—Hypotension—Vincristine—lymphatic system cancer	0.000799	0.00236	CcSEcCtD
Benazepril—Dyspnoea—Carmustine—lymphatic system cancer	0.000798	0.00236	CcSEcCtD
Benazepril—Somnolence—Carmustine—lymphatic system cancer	0.000796	0.00235	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000779	0.0023	CcSEcCtD
Benazepril—Hypotension—Mitoxantrone—lymphatic system cancer	0.000778	0.0023	CcSEcCtD
Benazepril—Insomnia—Vincristine—lymphatic system cancer	0.000773	0.00228	CcSEcCtD
Benazepril—Paraesthesia—Vincristine—lymphatic system cancer	0.000768	0.00227	CcSEcCtD
Benazepril—Constipation—Carmustine—lymphatic system cancer	0.000766	0.00226	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000758	0.00224	CcSEcCtD
Benazepril—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000756	0.00223	CcSEcCtD
Benazepril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000748	0.00221	CcSEcCtD
Benazepril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000742	0.00219	CcSEcCtD
Benazepril—Somnolence—Mitoxantrone—lymphatic system cancer	0.00074	0.00219	CcSEcCtD
Benazepril—Fatigue—Vincristine—lymphatic system cancer	0.000737	0.00218	CcSEcCtD
Benazepril—Asthenia—Bleomycin—lymphatic system cancer	0.000736	0.00217	CcSEcCtD
Benazepril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000733	0.00217	CcSEcCtD
Benazepril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000732	0.00216	CcSEcCtD
Benazepril—Constipation—Vincristine—lymphatic system cancer	0.000731	0.00216	CcSEcCtD
Benazepril—Asthma—Methotrexate—lymphatic system cancer	0.000729	0.00215	CcSEcCtD
Benazepril—Pruritus—Bleomycin—lymphatic system cancer	0.000726	0.00214	CcSEcCtD
Benazepril—Eosinophilia—Methotrexate—lymphatic system cancer	0.000722	0.00213	CcSEcCtD
Benazepril—Fatigue—Mitoxantrone—lymphatic system cancer	0.000718	0.00212	CcSEcCtD
Benazepril—Pancreatitis—Methotrexate—lymphatic system cancer	0.000715	0.00211	CcSEcCtD
Benazepril—Constipation—Mitoxantrone—lymphatic system cancer	0.000712	0.0021	CcSEcCtD
Benazepril—Abdominal pain—Carmustine—lymphatic system cancer	0.000708	0.00209	CcSEcCtD
Benazepril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000699	0.00207	CcSEcCtD
Benazepril—Neutropenia—Methotrexate—lymphatic system cancer	0.000682	0.00202	CcSEcCtD
Benazepril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000681	0.00201	CcSEcCtD
Benazepril—Abdominal pain—Vincristine—lymphatic system cancer	0.000676	0.002	CcSEcCtD
Benazepril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000672	0.00198	CcSEcCtD
Benazepril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000666	0.00197	CcSEcCtD
Benazepril—Hypersensitivity—Carmustine—lymphatic system cancer	0.00066	0.00195	CcSEcCtD
Benazepril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000658	0.00194	CcSEcCtD
Benazepril—Vomiting—Bleomycin—lymphatic system cancer	0.000652	0.00193	CcSEcCtD
Benazepril—Rash—Bleomycin—lymphatic system cancer	0.000647	0.00191	CcSEcCtD
Benazepril—Dermatitis—Bleomycin—lymphatic system cancer	0.000646	0.00191	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000645	0.0019	CcSEcCtD
Benazepril—Asthenia—Carmustine—lymphatic system cancer	0.000643	0.0019	CcSEcCtD
Benazepril—Hypersensitivity—Vincristine—lymphatic system cancer	0.00063	0.00186	CcSEcCtD
Benazepril—Sweating—Methotrexate—lymphatic system cancer	0.000623	0.00184	CcSEcCtD
Benazepril—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000613	0.00181	CcSEcCtD
Benazepril—Asthenia—Vincristine—lymphatic system cancer	0.000613	0.00181	CcSEcCtD
Benazepril—Diarrhoea—Carmustine—lymphatic system cancer	0.000613	0.00181	CcSEcCtD
Benazepril—Nausea—Bleomycin—lymphatic system cancer	0.000609	0.0018	CcSEcCtD
Benazepril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000607	0.00179	CcSEcCtD
Benazepril—Asthenia—Mitoxantrone—lymphatic system cancer	0.000597	0.00176	CcSEcCtD
Benazepril—Dizziness—Carmustine—lymphatic system cancer	0.000592	0.00175	CcSEcCtD
Benazepril—Diarrhoea—Vincristine—lymphatic system cancer	0.000585	0.00173	CcSEcCtD
Benazepril—Hepatitis—Methotrexate—lymphatic system cancer	0.000584	0.00172	CcSEcCtD
Benazepril—Pharyngitis—Methotrexate—lymphatic system cancer	0.000579	0.00171	CcSEcCtD
Benazepril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00057	0.00168	CcSEcCtD
Benazepril—Vomiting—Carmustine—lymphatic system cancer	0.000569	0.00168	CcSEcCtD
Benazepril—Dizziness—Vincristine—lymphatic system cancer	0.000565	0.00167	CcSEcCtD
Benazepril—Rash—Carmustine—lymphatic system cancer	0.000565	0.00167	CcSEcCtD
Benazepril—Dermatitis—Carmustine—lymphatic system cancer	0.000564	0.00167	CcSEcCtD
Benazepril—Headache—Carmustine—lymphatic system cancer	0.000561	0.00166	CcSEcCtD
Benazepril—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000552	0.00163	CcSEcCtD
Benazepril—Tinnitus—Methotrexate—lymphatic system cancer	0.000544	0.00161	CcSEcCtD
Benazepril—Vomiting—Vincristine—lymphatic system cancer	0.000544	0.00161	CcSEcCtD
Benazepril—Rash—Vincristine—lymphatic system cancer	0.000539	0.00159	CcSEcCtD
Benazepril—Dermatitis—Vincristine—lymphatic system cancer	0.000538	0.00159	CcSEcCtD
Benazepril—Headache—Vincristine—lymphatic system cancer	0.000536	0.00158	CcSEcCtD
Benazepril—Nausea—Carmustine—lymphatic system cancer	0.000532	0.00157	CcSEcCtD
Benazepril—Vomiting—Mitoxantrone—lymphatic system cancer	0.000529	0.00156	CcSEcCtD
Benazepril—Rash—Mitoxantrone—lymphatic system cancer	0.000525	0.00155	CcSEcCtD
Benazepril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000524	0.00155	CcSEcCtD
Benazepril—Headache—Mitoxantrone—lymphatic system cancer	0.000522	0.00154	CcSEcCtD
Benazepril—Alopecia—Methotrexate—lymphatic system cancer	0.000516	0.00152	CcSEcCtD
Benazepril—Nausea—Vincristine—lymphatic system cancer	0.000508	0.0015	CcSEcCtD
Benazepril—Nausea—Mitoxantrone—lymphatic system cancer	0.000495	0.00146	CcSEcCtD
Benazepril—Back pain—Methotrexate—lymphatic system cancer	0.000492	0.00145	CcSEcCtD
Benazepril—Vertigo—Methotrexate—lymphatic system cancer	0.000457	0.00135	CcSEcCtD
Benazepril—Leukopenia—Methotrexate—lymphatic system cancer	0.000455	0.00134	CcSEcCtD
Benazepril—Cough—Methotrexate—lymphatic system cancer	0.000443	0.00131	CcSEcCtD
Benazepril—Myalgia—Methotrexate—lymphatic system cancer	0.000433	0.00128	CcSEcCtD
Benazepril—Chest pain—Methotrexate—lymphatic system cancer	0.000433	0.00128	CcSEcCtD
Benazepril—Arthralgia—Methotrexate—lymphatic system cancer	0.000433	0.00128	CcSEcCtD
Benazepril—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000415	0.00123	CcSEcCtD
Benazepril—Infection—Methotrexate—lymphatic system cancer	0.000412	0.00122	CcSEcCtD
Benazepril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000406	0.0012	CcSEcCtD
Benazepril—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000401	0.00118	CcSEcCtD
Benazepril—Hypotension—Methotrexate—lymphatic system cancer	0.000388	0.00115	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000378	0.00112	CcSEcCtD
Benazepril—Insomnia—Methotrexate—lymphatic system cancer	0.000375	0.00111	CcSEcCtD
Benazepril—Paraesthesia—Methotrexate—lymphatic system cancer	0.000372	0.0011	CcSEcCtD
Benazepril—Dyspnoea—Methotrexate—lymphatic system cancer	0.00037	0.00109	CcSEcCtD
Benazepril—Somnolence—Methotrexate—lymphatic system cancer	0.000369	0.00109	CcSEcCtD
Benazepril—Dyspepsia—Methotrexate—lymphatic system cancer	0.000365	0.00108	CcSEcCtD
Benazepril—Fatigue—Methotrexate—lymphatic system cancer	0.000358	0.00106	CcSEcCtD
Benazepril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000339	0.001	CcSEcCtD
Benazepril—Abdominal pain—Methotrexate—lymphatic system cancer	0.000328	0.000969	CcSEcCtD
Benazepril—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000306	0.000903	CcSEcCtD
Benazepril—Asthenia—Methotrexate—lymphatic system cancer	0.000298	0.000879	CcSEcCtD
Benazepril—Pruritus—Methotrexate—lymphatic system cancer	0.000293	0.000867	CcSEcCtD
Benazepril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000284	0.000838	CcSEcCtD
Benazepril—Dizziness—Methotrexate—lymphatic system cancer	0.000274	0.00081	CcSEcCtD
Benazepril—Vomiting—Methotrexate—lymphatic system cancer	0.000264	0.000779	CcSEcCtD
Benazepril—Rash—Methotrexate—lymphatic system cancer	0.000262	0.000773	CcSEcCtD
Benazepril—Dermatitis—Methotrexate—lymphatic system cancer	0.000261	0.000772	CcSEcCtD
Benazepril—Headache—Methotrexate—lymphatic system cancer	0.00026	0.000768	CcSEcCtD
Benazepril—Nausea—Methotrexate—lymphatic system cancer	0.000246	0.000728	CcSEcCtD
